En Es
Categories

Industry News

Fujifilm and IU School of Medicine to Study AI in Diagnostic Imaging

By Medimaging International staff writers
12 Sep 2018

Image: Researchers are working to develop the application of AI in medical imaging diagnostics (Photo courtesy of Digital Health).Fujifilm Corporation (Tokyo, Japan) has entered into a joint research agreement with Indiana University School of Medicine (Indianapolis, IN, USA) to develop the application of artificial intelligence (AI) in medical imaging diagnostic support systems.

Going forward, as clinical information is increasingly viewed in the context of big data, AI technology will be applied to develop products that meet the different and challenging needs of the healthcare industry. For instance, recent technological advancements in diagnostic imaging system capabilities, such as multi-slice CT, have created the need for an efficient solution to read and interpret the increased number of images being generated. The application of AI technology to support physicians by detecting suspicious lesions in images, comparing results with prior studies and the implementation of semi-automated reporting is expected to significantly increase the efficiency of diagnostic medical imaging in patient care.

Fujifilm is using AI technology to develop image diagnosis support systems, which will support the overall diagnostic workflow of physicians. In addition to undertaking various in-house development projects, Fujifilm is also entering into a partnership with leading AI technology vendors to expand the disease coverage of its systems. The Indiana University School of Medicine is affiliated with Indiana University Health (IU Health), a medical healthcare system with 17 hospitals and about 33,000 employees in the US.

The collaboration aims to combine Fujifilm’s image processing and AI technology with the Indiana University School of Medicine’s rich diagnostic and clinical expertise to develop medical AI technology, while searching for a system optimized to support diagnosis workflow. The research will initially utilize Fujifilm’s AI technology to segment and quantify muscle atrophy (sarcopenia) in body images, as well as detect and quantify brain lesions in neuroradiology imaging exams.



E-mail Print
FaceBook Twitter Google+ Linked in

Fujifilm

Offers diagnostic imaging products, including FCR” digital x-ray imaging and diagnostic systems, “Synapse” medical-use picture archiving and communications systems (PACS), dry imaging films/dry imagers, X-ray films, radiopharmaceuticals, digital endoscopes, nucleic acid isolation systems, healthcare products and pharmaceutical
More info

More articles about Fujifilm

24 Apr 2018
Fujifilm Showcases Extended Product Line at ECR 2018
Fujifilm Medical Systems Europe, a provider of diagnostic imaging products and medical informatics solutions, showcased its broad, enhanced line up of products and solutions at the European Congress of Radiology (ECR) 2018. The products and solutions showcased by Fujifilm at ECR 2018 focused on women’s health, healthcare IT, artificial intelligence (AI), digital radiography (DR), computed tomography (CT), computed radiography and ultrasound.
Read More

Additional news

06 Jul 2019
ACR Expands Pilot Program Focused on AI and Radiology
Radiology professionals from seven renowned health care institutions will use the ACR AI-LAB to demonstrate the process of creating investigational artificial intelligence (AI) models from image data without the use of a programming language.
Read More
06 Jul 2019
Konica Minolta Offers AI-Based Cardiac Ultrasound Analysis
Konica Minolta Healthcare Americas Inc, a provider of medical diagnostic imaging and healthcare information technology, has announced a partnership with DiA Imaging Analysis, a provider of artificial intelligence (AI) powered ultrasound analysis solutions.
Read More
06 Jul 2019
VR and AI Drive Exponential Growth in Integrated Operating Rooms
The operating room (OR) is transforming from a seemingly simple box into a technology-powered, infection-free, and sleek surgical environment.
Read More
06 Jul 2019
AI-Based Image Reconstruction Solution Receives FDA Clearance
Canon Medical Systems USA, Inc. has received 510(k) clearance from the FDA for its new deep convolutional neural network (DCNN) image reconstruction technology.
Read More
06 Jul 2019
Bracco Imaging Acquires Blue Earth Diagnostics to Expand Portfolio
Bracco Imaging S.p.A. has signed a definitive agreement to acquire Blue Earth Diagnostics, a molecular imaging company.
Read More
06 Jul 2019
AI Approach Lowers Radiation Exposure from CT Imaging
Engineers at the Rensselaer Polytechnic Institute worked along with radiologists at Massachusetts General Hospital and Harvard Medical School to demonstrate that machine learning has the potential to vastly advance medical imaging, particularly computerized tomography (CT) scanning, by reducing radiation exposure and improving image quality.
Read More
06 Jul 2019
New AI-based Method Detects Brain Response to MS Treatment
Researchers at University College London and King's College London have developed a new artificial intelligence (AI)-based method for detecting the brain's response to treatment in multiple sclerosis (MS).
Read More
06 Jul 2019
Global Molecular Diagnostics Market to Reach USD 13.87 Billion by 2025
The global molecular diagnostics market was valued at USD 8 billion in 2017 and is projected to grow at a CAGR of 7.1% during the period 2018 to 2025 to reach USD 13.87 billion by 2025.
Read More
06 Jul 2019
Global Surgical Imaging Market to Reach USD 1.49 Billion by 2026
The global surgical imaging market was estimated to be worth USD 1.06 billion in 2018 and is projected to grow at a CAGR of 4.3% during the period 2019–2026 to reach USD 1.49 billion by 2026.
Read More
Copyright © 2000-2019 TradeMed.com. All rights reserved. | Terms And Conditions